41
Vernon G Wong, Mae W L Hu: Methods for treating inflammation-mediated conditions of the eye. Oculex Pharmaceuticals, Morrison & Foerster, April 27, 2004: US06726918 (108 worldwide citation)

Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal anti-inflammatory agent and a bioerodible polymer, wherein the implant delivers the agent to the vitreous ...


42
Sebastiano Bianco: Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation. B S D Bio Science Development SNC DI Omini C & Zuccari G, Finnegan Henderson Farabow Garrett & Dunner L, April 18, 2000: US06051566 (104 worldwide citation)

Non-steroidal anti-inflammatory drugs proved to be effective drugs for combating and preventing asthma if administered by inhalation. Useful are for instance acetylsalicylic acid, and indomethacin, and ketoprofen, and tenoxicam. Suitable pharmaceutical compositions for inhalation are aerosols with a ...


43
Eaton Donald J, Moran Mary L, Brenneman Rodney: Sinus delivery of sustained release therapeutics. Sinexus, Eaton Donald J, Moran Mary L, Brenneman Rodney, AMII Lisa A, September 30, 2004: WO/2004/082525 (100 worldwide citation)

The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biod ...


44
Jackie H McClung: Composition for topical application to skin. Jackie H McClung, Crowe & Dunlevy P C, June 17, 2003: US06579543 (98 worldwide citation)

A composition for topical application to an animal's skin for relief from a variety of symptoms caused by medical conditions or physical injuries. The composition includes at least one compound having analgesic activity, at least one compound having anti-inflammatory activity, at least one comp ...


45
John J Piwinski, Ashit K Ganguly, Michael J Green, Frank J Villani, Jesse Wong: Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies. Schering Corporation, James R Nelson, February 18, 1992: US05089496 (96 worldwide citation)

Derivatives of benzo[5,6]cyclohepta pyridine, and pharmaceutically acceptable salts and solvates thereof are disclosed, which possess anti-allergic and anti-inflammatory activity. Methods for preparing and using the compounds are also described.


46
Bret A Ferree: Treating degenerative disc disease through transplantation of allograft disc and vertebral endplates. Gifford Krass Groh Sprinkle Anderson & Citkowski PC, February 5, 2002: US06344058 (94 worldwide citation)

The intervertebral disc and a portion of adjacent vertebrae obtained from recently deceased human or animal donors are used to restore disc function and eliminate pain in patients with disc disease. Cells harvested and cultured from the nucleus pulposus and/or the annulus fibrosis of a normal disc a ...


47
Bret A Ferree: Treating degenerative disc disease through transplantation of the nucleus pulposis. Gifford Krass Groh Sprinkle Anderson & Citkowski PC, July 16, 2002: US06419702 (93 worldwide citation)

Living nucleus pulposis cells and extracellular matrix obtained from recently deceased human or animal donors are used to restore disc function and eliminate pain in patients with disc disease. In the preferred embodiment, the donor nucleus is morselized to allow insertion through a small puncture i ...


48
Francis Alfred Billson, Philip Leslie Penfold: Treatment of macular degeneration. The University of Sydney, Jenkins & Wilson P A, June 23, 1998: US05770589 (92 worldwide citation)

In the treatment of age-related macular degeneration, a method for treating an inflammatory response in the macula of the eye by use of a depot injection of a suitable anti-inflammatory agent into the vitreous humour is described. Triamcinolone acetomide (T) is employed which is in crystalline form ...


49
Gordon H Phillipps, Brian M Bain, Ian P Steeples, Christopher Williamson: Androstane carbothioates. Glaxo Group, Bacon & Thomas, June 15, 1982: US04335121 (88 worldwide citation)

Compounds of the formula ##STR1## wherein R.sup.1 represents a fluoro-, chloro- or bromo-methyl group or a 2'-fluoroethyl group, R.sup.2 represents a group COR.sup.6 where R.sup.6 is a C.sub.1-3 alkyl group or OR.sup.2 and R.sup.3 together form a 16.alpha.,17.alpha.-isopropylidenedioxy group; R.sup. ...


50
Amarjit Singh, Rajesh Jain, Anil Kumar Singla: Pharmaceutical composition for the control and treatment of anorectal and colonic diseases. Panacea Biotech, University Institute of Pharmaceutical Sciences, Morrison and Foerster, January 12, 1999: US05858371 (85 worldwide citation)

A Novel composition and a method for treating anorectal diseases including hemorrhoids and colonic diseases with long term effectiveness and low prolapse rates is disclosed. The compositions are water soluble and can be uniformly applied in the affected region. The composition comprises Flavonoidal ...



Click the thumbnails below to visualize the patent trend.